Royalty payment

Exelixis Announces Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Mardi, février 6, 2024

In 2023, global cabozantinib franchise net product revenues generated by Exelixis and its partners exceeded $2.2 billion.

Key Points: 
  • In 2023, global cabozantinib franchise net product revenues generated by Exelixis and its partners exceeded $2.2 billion.
  • Based upon cabozantinib-related net product revenues generated by Exelixis’ collaboration partners during the quarter and year ended December 31, 2023, Exelixis earned $40.7 million and $148.5 million, respectively, in royalty revenues.
  • In October 2023, detailed results were presented from the phase 3 CABINET pivotal trial at the 2023 ESMO Congress.
  • Exelixis management will discuss the company’s financial results for the fourth quarter and fiscal year of 2023 and provide a general business update during a conference call beginning at 5:00 p.m.

Cielo Announces Extension of Deadline to Pay Royalties

Retrieved on: 
Vendredi, janvier 12, 2024

CALGARY, Alberta, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Cielo Waste Solutions Corp. (TSXV:CMC; OTCQB:CWSFF) (“Cielo” or the “Company”), a waste-to-fuel environmental technology company, announces today that it has extended the date by which it is required to pay royalties (the “Royalties”) to July 3, 2024.

Key Points: 
  • CALGARY, Alberta, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Cielo Waste Solutions Corp. (TSXV:CMC; OTCQB:CWSFF) (“Cielo” or the “Company”), a waste-to-fuel environmental technology company, announces today that it has extended the date by which it is required to pay royalties (the “Royalties”) to July 3, 2024.
  • In 2018, the Company had undertaken an early warrant exercise incentive program, issuing a $0.0875 fixed rate royalty for each of the 10,162,500 warrants that were exercised.
  • The deadline to pay the Royalties was originally July 3, 2020, which was extended in July 2020 and again in July 2022, requiring repayment in January 2024.
  • The Company is pleased to have received the required approval from the holders of the Royalties for the extension to July 2024, allowing the Company to focus its resources on the further development of its first commercial waste-to-fuel project in Carseland, Alberta.

Euro Manganese Reports Fourth Quarter and Year-End 2023 Financial Results and Project Developments

Retrieved on: 
Jeudi, décembre 14, 2023

VANCOUVER, British Columbia, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Euro Manganese Inc. (TSX-V and ASX: EMN; OTCQX: EUMNF; Frankfurt: E06) (the "Company" or "EMN") is pleased to announce key developments during the fourth fiscal quarter 2023 and to date.

Key Points: 
  • VANCOUVER, British Columbia, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Euro Manganese Inc. (TSX-V and ASX: EMN; OTCQX: EUMNF; Frankfurt: E06) (the "Company" or "EMN") is pleased to announce key developments during the fourth fiscal quarter 2023 and to date.
  • The Company has now filed its September 30, 2023 year-end Financial Statements, Management’s Discussion and Analysis, and other financial reports.
  • US$100 million non-dilutive funding package announced to advance development of the Chvaletice Manganese Project (the "Project"); US$20 million received on closing.
  • The Chvaletice Project received high-level inter-governmental support during the fourth calendar quarter by being named as a project under the Minerals Security Partnership.

Sound Royalties Accelerates Company Growth by Creating Business Relationship with Music Banking Veteran David Innes

Retrieved on: 
Mercredi, novembre 8, 2023

MIAMI, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Sound Royalties , a subsidiary of GoDigital Media Group and the music industry’s leading finance firm for nearly a decade, is continuing to accelerate its growth strategies by announcing a new working relationship with David Innes.

Key Points: 
  • MIAMI, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Sound Royalties , a subsidiary of GoDigital Media Group and the music industry’s leading finance firm for nearly a decade, is continuing to accelerate its growth strategies by announcing a new working relationship with David Innes.
  • The entertainment banking veteran will support Sound Royalties by amplifying its networking reach among music creatives and expanding its new business pipeline.
  • “Sound Royalties continues to experience strong growth, and with the current prime rate at 8.5%, our fixed fee and fixed term funding has become even more appealing to the marketplace.
  • His new venture, On the Money Entertainment Advisory and Consulting, will work with Sound Royalties to align music creatives with the right resources to support their projects.

Inventiva announces a financing of approximately €35.7 million from new and existing investors, consisting of a €30.6 million reserved capital increase and a €5.1 million issuance of royalty certificates

Retrieved on: 
Jeudi, août 31, 2023

As a result, the Company will not have sufficient net working capital over the next twelve months after the Capital Increase and the issuance of the Royalty Certificates.

Key Points: 
  • As a result, the Company will not have sufficient net working capital over the next twelve months after the Capital Increase and the issuance of the Royalty Certificates.
  • After the Capital Increase, Sofinnova Partner will hold 9.8% of the share capital of the Company, on a non-diluted basis.
  • After the Capital Increase, Yiheng Capital will hold 7.4% of the share capital of the Company, on a non-diluted basis.
  • The Royalty Certificates will not be listed on any stock exchange and will not be assigned an ISIN.

Osisko Announces Royalty Transaction With Hot Chili on the Costa Fuego Copper-Gold Project in Chile

Retrieved on: 
Mercredi, juin 28, 2023

MONTREAL, June 28, 2023 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd (“Osisko”) (OR: TSX & NYSE) is pleased to announce that it has entered into a binding agreement to acquire a 1.0% copper net smelter return (“NSR”) royalty and a 3.0% gold NSR royalty (the “Royalties”) from Hot Chili Limited (“Hot Chili”) covering Hot Chili’s Costa Fuego Copper-Gold Project (“Costa Fuego” or the “Project”) in Chile, for total cash consideration of US$15.0 million.

Key Points: 
  • MONTREAL, June 28, 2023 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd (“Osisko”) (OR: TSX & NYSE) is pleased to announce that it has entered into a binding agreement to acquire a 1.0% copper net smelter return (“NSR”) royalty and a 3.0% gold NSR royalty (the “Royalties”) from Hot Chili Limited (“Hot Chili”) covering Hot Chili’s Costa Fuego Copper-Gold Project (“Costa Fuego” or the “Project”) in Chile, for total cash consideration of US$15.0 million.
  • Osisko has granted Hot Chili an option to buy down a portion of the royalty, which can only occur upon change of control and exercisable until the fourth anniversary of the transaction close.
  • Should Hot Chili’s ownership of these properties increase, the royalty will thereafter apply to the increased ownership level.
  • Productora is held in a joint venture, presently 80% owned by Hot Chili and Cortadera is 100% owned by Hot Chili.

Royal Gold Announces Commitment to Acquire Gold/Platinum/Palladium and Copper/Nickel Royalties on Producing Serrote and Santa Rita Mines in Brazil

Retrieved on: 
Lundi, juin 12, 2023

The royalty interests consist of a gold royalty on the Serrote mine, a gold, platinum and palladium royalty on the Santa Rita mine, and a copper and nickel royalty on both the Serrote and Santa Rita mines (collectively, the “Royalties”).

Key Points: 
  • The royalty interests consist of a gold royalty on the Serrote mine, a gold, platinum and palladium royalty on the Santa Rita mine, and a copper and nickel royalty on both the Serrote and Santa Rita mines (collectively, the “Royalties”).
  • “I am pleased to announce this proposed acquisition of royalties on two attractive producing mines,” commented Bill Heissenbuttel, President and CEO of Royal Gold.
  • At the Santa Rita mine, an underground expansion project could provide a 27-year extension to the mine life.
  • The royalties will be effective as of May 1, 2023, and revenue to Royal Gold will be accrued from that date.

Exelixis Announces First Quarter 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Mardi, mai 9, 2023

Based upon cabozantinib-related net product revenues generated by Exelixis’ collaboration partners during the quarter ended March 31, 2023, Exelixis earned $32.7 million in royalty revenues.

Key Points: 
  • Based upon cabozantinib-related net product revenues generated by Exelixis’ collaboration partners during the quarter ended March 31, 2023, Exelixis earned $32.7 million in royalty revenues.
  • Cabozantinib Data at the 2023 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium (ASCO GU 2023).
  • This IND clearance triggered a $35.0 million milestone payment to Sairopa, paid in the first quarter of 2023.
  • Exelixis management will discuss the company’s financial results for the first quarter of 2023 and provide a general business update during a conference call beginning at 5:00 p.m.

Everspin Reports Unaudited First Quarter 2023 Financial Results

Retrieved on: 
Mercredi, mai 3, 2023

Everspin Technologies, Inc. (NASDAQ: MRAM), the market leader in MRAM, today announced preliminary unaudited financial results for the first quarter ended March 31, 2023.

Key Points: 
  • Everspin Technologies, Inc. (NASDAQ: MRAM), the market leader in MRAM, today announced preliminary unaudited financial results for the first quarter ended March 31, 2023.
  • Gross margin for the first quarter of 2023 was 56.8%, compared to 51.4% in the fourth quarter of 2022 and 58.0% in the first quarter of 2022.
  • For the second quarter 2023, Everspin expects total revenue in a range of $14.5 million to $15.5 million.
  • Everspin encourages investors to review its financial statements and publicly-filed reports in their entirety and not to rely on any single financial measure.

Alkermes Announces Second Interim Award in Janssen Pharmaceutica Arbitration

Retrieved on: 
Mardi, avril 25, 2023

DUBLIN, April 25, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that on April 19, 2023 it received a second interim award (the "Second Interim Award") from the arbitral tribunal (the "Tribunal") in its arbitration proceedings in respect of two license agreements with Janssen Pharmaceutica N.V. ("Janssen"), a subsidiary of Johnson & Johnson.

Key Points: 
  • DUBLIN, April 25, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that on April 19, 2023 it received a second interim award (the "Second Interim Award") from the arbitral tribunal (the "Tribunal") in its arbitration proceedings in respect of two license agreements with Janssen Pharmaceutica N.V. ("Janssen"), a subsidiary of Johnson & Johnson.
  • Pursuant to the Second Interim Award:
    - Back royalties related to fiscal year 2022 of approximately $194 million (inclusive of interest) are due to Alkermes from Janssen under the two agreements.
  • The Second Interim Award follows the Interim Award issued by the Tribunal on Dec. 21, 2022, in which the Tribunal found that, while Janssen may terminate the license agreements, it may not continue to sell Products (as defined in the license agreements) developed during the term of the license agreements without paying royalties pursuant to the terms of the respective agreements.
  • Alkermes does not intend to comment or provide additional information regarding the arbitration at this time.